Treatment of Chronic Anemia With Epoetin Alfa in Elderly

• Status: Unknown status
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if chronic anemia can be corrected with epoetin alfa and does the subsequent correction lead to an improvement in fatigue,quality of life or mobility among elderly.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Research and Education Foundation of Michael Reese Hospital
• Collaborators: John H. Stroger Hospital; Mercy Hospital and Medical Center, Illinois; Ortho Biotech Clinical Affairs, L.L.C.
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• 65 years of age or older Diagnosed with chronic anemia Hemoglobin level less than or equal to 11.5 g/dl Community dwelling Able to make monthly clinic visits

Exclusion Criteria:

• Currently on Epoetin alfa or similar preparations Having nutritional anemia Having active cancer or received recent treatment for cancer On treatment for Kidney disease Diagnosis of dementia Inability to ambulate